Join Duchenne UK and help drive forward groundbreaking research and support for the Duchenne community
NICE has recommended givinostat to treat Duchenne in NHS England
Responding to SEND reform consultation
Three new Duchenne Care UK psychosocial clinical guidelines
Update on Duchenne research and emerging treatments
Roche has announced new clinical study of Elevidys
New research opportunity in partnership with Action Medical Research
Duchenne UK joins families in Northern Ireland campaigning for the EAP
Givinostat recommended for approval in the EU
Second hospital Trust starts dosing with givinostat under Early Access Programme
Roche temporarily halts clinic studies
European Commission decides not to renew the market authorisation of Translarna (ataluren)
